ABSTRACT
Resumen: El panel intergubernamental sobre cambio climático estima que para el año 2100 74% de la población estará expuesta a olas de calor en el peor escenario (definido como 3 días consecutivos con temperaturas igual o sobre el percentil 95 de un periodo de tiempo), abarcando en Santiago hasta 40% de los días de verano con temperaturas extremas. Producto de la crisis climática también pueden ocurrir eventos de frío extremo. Ambos fenómenos constituyen un riesgo para la salud, particularmente para las enfermedades cardiovasculares. Objetivo: Estudiar la asociación entre temperaturas extremas y enfermedades cardiovasculares (mortalidad por enfermedades cardiovasculares, infarto agudo al miocardio, accidente cerebrovascular, hipertensión y paro cardíaco extra hospitalario). Métodos: Se realizó una revisión bibliográfica en los buscadores ISI-Web of Science, Scopus y Nature utilizando los términos de búsqueda heatwave, cardiovascular disease y extreme heat entre los años 2016-2021 incluyendo trabajos que presenten medidas de asociación entre temperaturas extremas (percentil 5 para temperaturas bajas y percentil 90 para temperaturas altas) y enfermedades cardiovasculares, arrojando 130 resultados de los cuales se seleccionaron 19. Resultados: Tanto las temperaturas altas como bajas aumentaron el riesgo de muerte por infarto agudo al miocardio (IAM) (RR: 2,29 [2,18-2,40] y RR: 2,3 [1,2-4,6], respectivamente) y paro cardíaco (OR 3,34 [1,90-3,58] y OR: 1,75 [1,23-2,49], respectivamente). La mortalidad por hipertensión arterial se asoció a temperaturas altas (OR 1,91 [1,2-3,1]), mientras que la mortalidad por enfermedades cardiovasculares (ECV) en general a bajas (RR: 1,79 [1,64 - 1,95]). En hospitalizaciones por ECV el riesgo por temperaturas altas (P99) fue RR: 1,74 [IC95%: 1,30-2,32]. Se identificaron diferencias por sexo y mayor riesgo en los mayores de 75 años y quienes presentaron exposiciones prolongadas. Conclusión: Hay una fuerte asociación entre hospitalizaciones y muerte por ECV y temperaturas extremas. Las mujeres y los adultos mayores son los más afectados.
Abstract: The Inter governmental panel estimates that in a worst case scenario, by 2100 74% of people will be exposed to heat waves (3 consecutive days with temperatures at or above the 95% percentile). This might be the case in up to 40% of days in Santiago. As a consequence of climate change there will also be periods with extremely low temperatures. Both conditions increase the risk of cardiovascular disease. Aim: to study the association of extreme temperatures with the incidence of cardiovascular disease (death, myocardial infarction, stroke and out of hospital sudden death). Method: The ISI-Web of Science, Scopus and Nature databases were searched using the terms "heat wave", "cardiovascular disease" and "extreme heat" for articles published between 2016 and 2021.
Subject(s)
Humans , Cardiovascular Diseases/etiology , Cardiovascular Diseases/epidemiology , Hot Temperature , Climate Change , Public Health , Global HealthABSTRACT
Background: There is no recent information on the incidence of acute myocardial infarction (AMI) in Chile. Aim: To describe and evaluate the temporal incidence trend of AMI in Chile between 2008 and 2016. Material and Methods: A time series study. We included all AMI cases (ICD10 = I21) that were registered in Chile between 2008 and 2016 in the national hospital discharge and death databases. Rates were stratified according to sex and age group. We calculated crude and standardized rates (direct method). Time trends were evaluated using Prais-Winsten (PW) regression models. Results: There were 132,784 cases of AMI. The mean age of cases was 67 ± 14 years, 67% were men. Crude and standardized rates were 84.4 and 73.1 cases per 100,000 inhabitants, respectively. Standardized incidence increased in total population and women, whose PW coefficients were 0.43 (0.01-0.82; p = 0.045) and 0.26 (0.005-0.47; p = 0.02), respectively. Regarding age, an upward trend was observed in the younger age groups, whose coefficients were 0.20 (0.08 − 0.31; p = 0.004) for cases < 45 years, 1.31 (0.81-1.81; p < 0.01) for cases between 45 and 54 years, and 2.68 (1.31 − 4.04; p = 0.002) for cases between 55 and 64 years. Conclusions: An increase in the number of cases with AMI was observed, especially in younger age groups. This estimation could be useful for planning and evaluating public policies.
Subject(s)
Humans , Male , Female , Infant , Middle Aged , Aged , Aged, 80 and over , Myocardial Infarction/epidemiology , Patient Discharge , Chile/epidemiology , Incidence , Databases, FactualABSTRACT
Background: Balloon pulmonary angioplasty (BPA) is a therapeutic alternative for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Aim: To report the initial experience with the "refined BPA technique" with the use of intravascular images. Patients and Methods: Between June 2015 and June 2016 we selected fourteen patients with CTEPH who were considered candidates for BPA. Lesions targeted for treatment were further analyzed using intravascular imaging with optical frequency domain imaging (OFDI). We report the immediate hemodynamic results and four weeks of follow-up of the first eight patients of this series. Results: We performed 16 BPA in eight patients aged 61 ± 14 years (88% women). Mean pulmonary artery pressure (PAPm) was 48.6 ± 5.8 mmHg. Success was achieved in seven patients (88%). A mean of 2.3 segments per patient were intervened in 11 sessions (1.6 sessions/ patient). Only one patient developed lung reperfusion injury. No mortality was associated with the procedure. After the last BPA session, PAPm decreased to 37.4 ± 8.6 mmHg (p=0.02). Pulmonary vascular resistance (RVP) decreased from 858,6 ± 377,0 at baseline to 516,6 ± 323,3 Dynes/sec/cm−5 (p<0.01) and the cardiac index increased from 2.4±0.6 at baseline to 2.8±0.3 L/min/m2 (p=0.01). At 4 weeks after the last BPA, WHO functional class improved from 3.3±0.5 to 2.5±0.5 (p<0,01) and six minutes walking distance from 331±92 to 451±149 m (p=0.01). Conclusions: BPA guided by OFDI for the treatment of inoperable CTEPH patients is a safe alternative with excellent immediate hemodynamic and clinical results.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Pulmonary Embolism/therapy , Angioplasty, Balloon/methods , Hypertension, Pulmonary/therapy , Pulmonary Embolism/physiopathology , Pulmonary Embolism/diagnostic imaging , Time Factors , Angiography/methods , Chronic Disease , Reproducibility of Results , Treatment Outcome , Tomography, Optical Coherence/methods , Hemodynamics , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/diagnostic imagingABSTRACT
Background: The incidence of acute myocardial infarction (AMI) varies according to seasonality, being higher in winter. The effect of sex on this phenomenon is not clear. Aim: To evaluate the effect of seasonality in men and women hospitalized for AMI at different ages. Material and Methods: We included all patients with a primary diagnosis of AMI admitted in public and private hospitals in Chile during 2002-2011 (codes I21-I22, of the tenth international classification of diseases). We obtained data from the National Discharge databases available at the Ministry of Health website. We estimated the number of discharges per month and per seasonality (cold /template), and the Standardized Incidence Ratio (SIR) with the formula: number of observed cases/expected cases (average annual hospitalizations), stratified by sex and age (< 50 years, 50-64 years, 6574 years, ≥ 75 years). We evaluated the effect of sex with binomial regressions for the different age strata. Results: We assessed 59,557 AMI hospitalizations (69% men, with and without ST elevation segment). May, June and July (austral winter) had a SIR of 1.10; 1.12 and 1.10, respectively. Women had a 20% excess of hospitalizations during cold seasons at any age. In men, the excess of hospitalizations increased from 9% in those aged < 50 years to 21% in those ≥ 75 years (p = 0.043). When comparing women and men, women aged < 50 years showed the higher risk of being hospitalized during cold seasons (adjusted risk ratio = 1.06; 95% confidence intervals 1.01-1.13). Conclusions: Women have a stronger seasonal pattern in AMI hospitalizations than men. While this effect increases with age in men, in women it remains constant at all ages.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Patient Admission/statistics & numerical data , Seasons , Myocardial Infarction/epidemiology , Patient Discharge/statistics & numerical data , Time Factors , Binomial Distribution , Chile/epidemiology , Sex Factors , Incidence , Multivariate Analysis , Age Factors , Sex Distribution , Age DistributionABSTRACT
Background: A low socioeconomic status is associated with higher overall mortality rates. Aim: To assess the effect of socioeconomic inequalities on survival of patients hospitalized with a first myocardial infarction. Material and Methods: Analysis of hospital discharge and mortality databases of the Ministry of Health. Patients aged over 15 years discharged between 2002 and 2011 with a first myocardial infarction (code I-21, ICD-10) were identified. Their survival was verified with the mortality registry. Survival from 0 to 28 and from 29 to 365 days was analyzed. Socioeconomic status was determined using the type of health insurance, stratified as public insurance (low and medium status) and private insurance (high status). Prais-Winsten trend (P-W) and Cox survival analyses were done. Results: We analyzed 59,557 patients (69% males). Sixty three percent were of low socioeconomic status, 19% medium and 18% high. Between 2002 and 2011 the increase in survival was higher among patients of low socioeconomic status, mainly in women (P-W coefficients 0.58:0.31-0.86 in men and 1.12:0.84-1.41 in women for 0-28 days survival and 0.24:0.09-0.39 in men and 0.48:0.37-0.60 in women for 29-365 days survival, respectively). However, age and year of hospitalization adjusted analysis showed a higher mortality risk among patients of low socioeconomic status at 0-28 days (HR 1.67:1.53-1.83 for men and 1.49:1.34-1.66 for women) and at 29-365 days (HR 2.30:1.75-2.71 for men and 1.90:1.56-1.85 for women). Conclusions: Survival after a myocardial infarction improved in the last decade especially in patients of low socioeconomic status. However, subjects of this stratum continue to have a higher mortality.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Social Class , Myocardial Infarction/mortality , Chile/epidemiology , Survival Rate , Longitudinal Studies , Sex DistributionABSTRACT
Introduction: eating disorders(ED)are chronic mental illnesses, highly prevalent within adolescent population, affecting women more than men. Generally, ED are triggered by an unsatisfactory self body-image, which relates to several socio-cultural factors. Objective: To study the prevalence of the risk of developing ED within Chilean high school students, and to evaluate its relation with sex and the school gender composition (SGC): single-sex or coeducational. Method: A transversal-analytic study was performed using three Santiago public high schools: female-exclusive, male-exclusive and coeducational. The Eating Attitudes Test-40 was applied, considering a 30-point score to define qualitatively the risk condition. Results: The sample included 415 students, 52 percent women, with a mean age of 15,9 years (range 14 to 18). The global prevalence of risk for ED was 14,9 percent. The risk condition was significantly higher in women (25,2 percent) than men (4 percent). No differences were found when comparing the prevalence of risk according to the type of school. Discussion: The higher risk for ED among women respect to men was confirmed, and the SGC has no influence on this risk.
Subject(s)
Male , Female , Humans , Adolescent , Feeding and Eating Disorders/epidemiology , Feeding and Eating Disorders/psychology , Sex Factors , Students , Chile , Cross-Sectional Studies , Feeding Behavior , Risk Assessment , Sex DistributionABSTRACT
Background: Socioeconomic status is associated with cardiovascular mortality. Aim: To evaluate the effect of educational level, on the prognosis of patients with acute myocardial infarction in Chile. Material and Methods: Cohort study of 3,636 patients aged 63.1 ± 13.2 years, 27% women, hospitalized in 16 centers participating in the Chilean Myocardial Infarction Registry (GEMI) between 2009 and 2012. Vital status was obtained from the National Mortality Database. Patients were divided, according to educational level, in four groups, namely none (no formal education), basic (< 8 years), secondary (8-12 years) and tertiary (> 12 years). Crude and adjusted (age, sex, cardiovascular risk factors and treatments) hazard ratios (HR) were estimated using Cox regression models. Results: The distribution by educational level was 3.2% none, 31.8% basic, 43.0% secondary and 22.0% tertiary. During a median follow-up period of 22 months (interquartile range 11-37 years), 631 patients died (17.3%), of whom 198 died during hospitalization (5.5%). The 30 day case-fatality rate according to educational level was 3.4% in tertiary, 4.7% in secondary, 11.9% in basic, 19.1% in none (p < 0.0001). Among patients surviving the first 30 days, the case-fatality rate was 4.4%, 8.6%, 14.6% and 27.0%, respectively (p < 0.0001). The increased risk of death for groups with lower education compared with individuals with tertiary education, persisted in the multivariate analysis with a hazard ratio for secondary education 1.58 (95% confidence intervals (CI), 1.18-2.10); for basic education 1.90 (95% CI, 1.41-2.47) and for none 3.50 (95% CI, 2.35-5.21). Conclusions: A lower educational level was associated with a worse prognosis in patients with myocardial infarction, even after controlling for potential confounding factors.
Subject(s)
Female , Humans , Male , Middle Aged , Educational Status , Myocardial Infarction/mortality , Chile/epidemiology , Cohort Studies , Registries , Social Class , Survival RateABSTRACT
Background: Intracoronary delivery of autologous bone marrow mononuclear cells is an interesting therapeutic promise for patients with heart failure of different etiologies. Aim: To evaluate the long-term safety and efficacy of this therapy in patients with dilated cardiomyopathy of different etiologies under optimal medical treatment. Patients and Methods: Prospective, open-label, controlled clinical trial. Of 23 consecutive patients, 12 were assigned to autologous bone marrow mononuclear cell intracoronary transplantation, receiving a mean dose of 8.19 ± 4.43 x 10(6) CD34+ cells. Mortality, cardiovascular readmissions and cancer incidence rate, changes in functional capacity, quality of life questionnaires and echocardiographic measures from baseline, were assessed at long-term follow-up (37.7 ± 9.7 months) in patients receiving or not the cells. Results: No significant differences were observed in mortality, cardiovascular readmissions or cancer incidence rate amongst groups. An improvement in functional class and quality of life questionnaires in the transplanted group was observed (p < 0.01). The treated group showed a non-significant increase in left ventricular ejection fraction at long-term follow-up (from 26.75 ± 4.85% to 34.90 ± 8.57%, p = 0.059 compared to baseline). There were no changes in left ventricular volumes. We observed no improvement of these variables in the control group. Conclusions: Intracoronary transplantation of autologous bone marrow mononuclear cells is feasible and safe in patients with dilated cardiomyopathy of diverse etiologies. This therapy was associated to persistent improvements in functional class and quality of life. There was also a non-significant long-term improvement of left ventricular function.
Subject(s)
Female , Humans , Male , Middle Aged , Bone Marrow Transplantation/methods , Cardiomyopathy, Dilated/surgery , Bone Marrow Transplantation/mortality , Cardiac Volume/physiology , Cardiomyopathy, Dilated/mortality , Cardiomyopathy, Dilated , Follow-Up Studies , Patient Readmission/statistics & numerical data , Prospective Studies , Quality of Life , Stroke Volume/physiology , Surveys and Questionnaires , Time Factors , Transplantation, Autologous , Treatment Outcome , Ventricular Function/physiologyABSTRACT
Background: In 2005, acute myocardial infarction (AMI) was included in a universal health plan (GES) to reduce inequity in care and optimize its diagnosis and treatment. Aim: To evaluate the effect of GES in risk factor control and therapeutic management among patients with AMI. Material and Methods: A survey was conducted in 2008-2009 in six public hospitals. Patients were identified from a hospital based registry of AMI and evaluated one year later with laboratory tests and an interview. Results: The registry enrolled 534 patients with ST and non ST segment elevation myocardial infarction. Of these, 416 patients aged 63 ± 12 years (25% women) were evaluated one year later. Eighty three percent were evaluated by a cardiologist and 37% by a general practitioner. Twenty two percent were evaluated by a nurse and 22% by a nutritionist. At the moment of the interview, 9% smoked, 78% were overweight or obese, 24% performed moderate or vigorous physical activity ≥ 150 min/week, 60% had systolic pressure > 130 mmHg and 63% a diastolic pressure > 80 mmHg. In 30%, LDL cholesterol was > 100 mg/dl and in 43%, triglycerides were > 150 mm/dl. Twenty two percent were diabetic and among them, 52% had a glycosilated hemoglobin > 7%. Forty five percent of non-diabetic patients had a fasting glucose > 100 mg/dl. Ninety three percent were in treatment with aspirin, 86% with statins, 66% with b-blockers, and 73% with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and 20% with clopidogrel. Conclusions: Despite the high proportion of patients in treatment with evidence-based therapy, many do not achieve the targets for risk factor control with the new health care model.
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Myocardial Infarction/prevention & control , Program Evaluation , Secondary Prevention/methods , Universal Health Insurance , Acute Disease , Chile/epidemiology , Follow-Up Studies , Hospitals, Public , Life Style , Myocardial Infarction/drug therapy , Myocardial Infarction/epidemiology , Registries/statistics & numerical data , Risk FactorsABSTRACT
Introducción: Estudios recientes indican que el trasplante intracoronario de células mononucleares de médula ósea (BMCs) autólogas, mejoran la fracción de eyección (FEVI) y otros marcadores clínicos en pacientes con insuficiencia cardíaca (IC). Objetivo: Evaluar la seguridad y eficacia de la administración intracoronaria de BMCs autólogas, en pacientes con insuficiencia cardíaca (IC) en fase dilatada, de diferente etiología y en óptimas condiciones de tratamiento médico. Método: De 23 pacientes consecutivos que cumplieron con los criterios de inclusión, 12 fueron asignados a trasplante intracoronario de BMCs autólogas, recibiendo una dosis media de 8.19+/-4.43 x 10(6) células CD34+ (Grupo trasplantado). Los pacientes restantes sólo recibieron terapia estándar (Grupo control). Todos los pacientes fueron evaluados mediante Electrocardiograma, Ecocardiografía, Holter ECG, RMN Cardíaca, Test de esfuerzo, Potenciales Ventriculares Tardíos, Variabilidad de Frecuencia Cardíaca y evaluación clínica a los 0, 3, 6 y 12 meses. La capacidad funcional (CF) fue evaluada clínicamente y por cuestionarios de calidad de vida. Elanálisis estadístico fue realizado mediante Test Anova, y test de Bonferroni. Resultados: El grupo trasplantado presentó un aumento significativo de la FEVI a los 6 meses (26.75+/-4.85 vs 37.82+/-6.97 por ciento, p=0.001) mejoría que se mantuvo a los 12 meses (26.75+/-4.85 vs 37.27+/-7.51 por ciento, p=0.002). Hubo una mejora significativa de la CF en el grupo trasplantado a los 6 y 12 meses (p<0.001). No hubo cambios significativos en los volúmenes de ventrículo izquierdo, así como en las restantes variables estudiadas. En el grupo control no observamos cambios de estas variables. No hubo complicaciones en relación al trasplante de BMCs. Conclusión: En pacientes con IC severa y baja FEVI, el trasplante intracoronario de células BMCs au-tólogas, se asoció a una mejoría significativa de la FEVI y la CF, a los 6 y 12 meses. Adicionalmente, no observamos ...
Background: Recent studies indicate that intra-coronary delivery of autologous bone marrow mono-nuclear cells (BMCs) improves the ejection fraction (LVEF) and other clinical markers in patients with heart failure (HF). Aim: To evaluate the safety and efficacy of intraco-ronary delivery of autologous BMCs in patients with HF in dilated phase under optimal medical treatment. Method: Of 23 consecutive patients who met the inclusion criteria, 12 were assigned to autologous BMCs intracoronary transplantation, receiving a mean dose of 8.19+/-4.43 x 106 CD34+ cells (BMCs group). The remaining patients received only standard therapy (control group). All patients were evaluated by Electrocardiogram, Echocardiography, Holter Monitoring, Cardiac Magnetic Resonance Imaging, Stress Testing, Ventricular Late potetials, Heart Rate Variability, and regular clinical examination at baseline and at follow-up (3, 6 and 12 months). Repeated measures ANOVA and Bonferroni testing were used for statistic analysis. Results: The BMCs group presented a significant increase in EF at sixth months (26.75+/-4.85 vs. 37.82+/-6.97 per cent, p=0.001) and 12 months post-transplant (26.75+/-4.85 vs. 37.27+/-7.51 per cent, p=0.002). There was a significant improvement in functional (NYHA) in the transplanted group at 6 and 12 months (p<0.001). There were no significant changes concerning left ventricular volumes, heart rate variability and exercise stress testing. We observed no improvement of these variables in the control group. There were no complications related to the BMCs transplant. Conclusions: Intracoronary infusion of auto-logous BMCs, in addition to standard therapy, was associated with significant improvement of left ventricular function at 12 months in patients with HF. We observed no complications relative to the procedure.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Bone Marrow Transplantation , Heart Failure/therapy , Ventricular Function , Analysis of Variance , Cardiomyopathy, Dilated/physiopathology , Follow-Up Studies , Single-Blind MethodABSTRACT
Background: Acute myocardial infarction (AMI) causes 73.6 percent of coronary heart disease (CHD) deaths in Chile. Aim: To estimate the incidence and case fatality of AMI and analyze their trends between 2001-2007. Material and Methods: A time-series study analyzing all cases of AMI (according to the International Classification of Diseases (ICD)-10, I21 code), registered in the National Hospitalizations and Death databases. Annual incidence rates and case fatality by sex and age groups were calculated. The direct method was used to standardize rates by age, using the World Health Organization 2000 Population. Prais-Winsten regression models were used to evaluate trends, expressed as relative change. Results: Between 2001 and 2007, we estimated that 83,754 cases of AMI occurred. Standardized annual incidence rate was 74.4 per 100,000 inhabitants (98.0 in men and 51.0 in women). Incidence rates increased by 34 percent in individuals < 45 years of age and 9.2 percent in the group 55-64 years (p < 0.001, both). Total case fatality was 49.5 percent (45.4 percent in men and 57.2 percent in women; p < 0.001), and its trend analysis showed a significant annual reduction of 1.2 percent in men and 0.81 percent in women. In-hospital case fatality was 14.2 percent (11.3 and 20.4 percent in men and women, respectively; p < 0.001). There was a significant annual reduction of mortality (0.57 and 1.01 percent in men and women, respectively (p < 0.05). Conclusions: The incidence of AMI was stable in the whole population, but increased in younger age groups. Total and in-hospital case-fatality decreased. Despite the greater reduction of case fatality in women, they still have a higher risk of dying while in hospital.
Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Hospital Mortality/trends , Myocardial Infarction/mortality , Acute Disease , Age Distribution , Chile/epidemiology , Incidence , Regression Analysis , Sex Distribution , Time FactorsABSTRACT
OBJETIVO: Describir las características de la mortalidad por cardiopatía isquémica en Chile y su evolución temporal, e identificar los factores asociados a mortalidad extrahospitalaria por esta patología entre 1997 y 2007. MÉTODOS. Estudio de serie temporal que utiliza las bases de defunciones del Departamento de Estadísticas e Información en Salud entre 1997 y 2007. De un total de 917 029 muertes notificadas, se seleccionaron aquellas cuya causa primaria fue cardiopatía isquémica (códigos I20 a I25 de la CIE-10). Se calcularon tasas crudas y ajustadas por edad y sexo para analizar la tendencia. Se analizaron las características de la mortalidad según el lugar de defunción, evaluando posibles factores asociados a mortalidad extrahospitalaria (casa/habitación u otro lugar), incluidos edad, ruralidad, estado civil, educación y sexo, así como el efecto de la incorporación del infarto agudo al miocardio a la ley de garantías en salud (GES), con regresión binomial. RESULTADOS: Durante el período estudiado se notificaron 87 342 muertes por cardiopatía isquémica, de las cuales 57,7 por ciento eran hombres y 59,5 por ciento ocurrieron fuera del hospital. La tasa de mortalidad ajustada por edad disminuyó de 52,9 a 40,4 por 100 000 habitantes. Los factores asociados a mortalidad extrahospitalaria en hombres fueron ruralidad, riesgo relativo (RR) 1,24 (1,21-1,27); edad mayor a 70 años, RR 1,03 (1,01-1,05); estado civil soltero, RR 1,10 (1,08-1,12), mientras que en las mujeres los valores correspondientes fueron 1,13 (1,10-1,18); 1,31 (1,27-1,36) y 1,07 (1,04-1,09). La adopción de la GES se asoció con un aumento en el porcentaje de muertes intrahospitalarias en mujeres, RR 0,95 (0,92-0,97). CONCLUSIONES: La mortalidad por cardiopatía isquémica en Chile ha disminuido. El mayor porcentaje de las muertes ocurren fuera de hospitales o clínicas. Los factores asociados a mortalidad extrahospitalaria en ambos sexos fueron edad avanzada, estado civil soltero y ruralidad.
OBJECTIVE: To describe the characteristics of mortality from ischemic heart disease in Chile and its trend over time, and to identify the factors associated with extra-hospital mortality from this pathology between 1997 and 2007. METHODS: A time-series study was conducted using the mortality database of the Department of Health Statistics and Information for 1997 to 2007. Of the total of 917 029 deaths reported in this period, those whose primary cause was ischemic heart disease (ICD-10 codes I20-I25) were selected. Crude and adjusted rates were calculated by age and sex in order to analyze the trend. Mortality characteristics were analyzed by the place of death, evaluating potential factors associated with extra-hospital mortality (death at home or elsewhere outside a hospital or clinic). The factors considered, using binomial regression, were age, rurality, marital status, education, and sex, as well as the effect of the incorporation of acute myocardial infarction into the explicit health guarantees law. RESULTS: During the period in question, 87 342 deaths from ischemic heart disease were reported, 57.7 percent of which were in males and 59.5 percent outside the hospital. The age-standardized mortality rate declined from 52.9 to 40.4 per 100 000 population. Factors related to extra-hospital mortality in men were rurality, relative risk (RR) 1.24 (1.21-1.27); age of over 70 years, RR 1.03 (1.01-1.05); and being single, RR 1.10 (1.08-1.12). In women, the respective values were rurality, 1.13 (1.10-1.18); advanced age, 1.31 (1.27-1.36); and being single, 1.07 (1.04-1.09). Passage of the explicit health guarantees law was associated with an increase in the percentage of in-hospital deaths in women, RR 0.95 (0.92-0.97). CONCLUSIONS: Mortality from ischemic heart disease in Chile has declined. The majority of deaths from this cause occur outside hospitals or clinics. The factors associated with extra-hospital mortality in both sexes were advanced age, being single, and rurality.
Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Myocardial Ischemia/mortality , Chile/epidemiologyABSTRACT
Background: Hyperglycemia at admission has been associated to an adverse prognosis in patients with ST-segment elevation acute myocardial infarction (STE-MI). However, its impact over the results of reperfusion therapies in patients with STEMI is still a matter of controversy. Aim: To determine the impact of admission hyperglycemia on hospital and long term mortality, according to the method of reper-fusion utilized in patients with STEMI. Material and Methods: Prospective registry of 1,634 consecutive patients aged 60 ± 12 years (77 percent male), from 3 participating hospitals in the Chilean Registry of Myocardial Infarction (GEMI). We evaluated demographic, clinical and laboratory variables, reperfusion method used, hospital and long term mortality. The impact of hyperglycemia on hospital and long term mortality was evaluated by a logistic regression analysis and Cox risk, respectively, adjusted by Thrombolysis in Myocardial Infarction (TIMI) risk score. Results: Twenty four percent of patients were diabetics and in 45 percent, the infarct was located on the anterior wall. The mean TIMI risk score was 3.2 ± 2.4. Hyperglycemia at entry was associated to a greater hospital and long term mortality, independently of the reperfusion strategy utilized. Primary angioplasty was associated to a greater benefit, compared to thrombolysis among hyperglycemic patients with an odds ratio: 2.9, 95 percent confi dence intervals: 1.0-8.0 and a hazard ratio of 2.9, 95 percent confi dence intervals: 1.44-5.88, independently of a previous history of diabetes mellitus and TIMI risk score. Conclusions: In patients with STEMI, admission hyperglycemia is associated with a worse prognosis which was significantly improved with primary angioplasty compared to thrombolysis, independently of the admission TIMI risk score.
Subject(s)
Female , Humans , Male , Middle Aged , Blood Glucose/analysis , Hospital Mortality , Hyperglycemia/mortality , Myocardial Infarction/mortality , Myocardial Reperfusion , Chile/epidemiology , Hyperglycemia/blood , Hyperglycemia/diagnosis , Logistic Models , Myocardial Infarction/diagnosis , Prognosis , Risk Factors , Sex Factors , Survival RateABSTRACT
Primary angioplasty is considered the best reperiusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperiusion method most commonly used, due to its wide availability, reduced costs and ease of administration. Aim: To compare inhospital mortality in STEMI patients according to reperiusion therapy. Material and Methods: Patients admitted to Chilean hospitals participating in the GEMI network, from 2001 to 2005, with STEMI were included. They were divided in three groups: a) treated with thrombolytics, b) treated with primary angioplasty, c) without reperiusion procedure. Inhospital mortality according to gender, was analized in each group, using a logistic regression method, to assess risk factors associated with mortality. Results: We included 3,255 patients. Global mortality was 9.9 percent (7.5 percent in men and 16.7 percent in women, p <0.001). Mortality in patients treated with thrombolytics, was 10.2 percent (7.6 percent in men and 18.7 percent in women, p <0.01). The figure for patients treated with primary angioplasty, was 4.7 percent (2.5 percent in men and 13 percent in women, p <0.01), and in patients without reperiusion, was 11.6 percent (9.8 percent in men and in 15.4 percent women, p <0.01). In each group women were older, had a higher prevalence of hypertension and a higher percentage of Killip 3-4 infarctions. Logistic regression showed that angioplasty, compared with no reperiusion, was associated with a reduced mortality only in men. The use oí thrombolytics in women was associated with a higher mortality. Conclusions: Primary angioplasty was the reperiusion therapy associated to the lower mortality in STEMI. Use of thrombolytics in women was associated with a higher mortality rate than in non reperfused women.
Subject(s)
Female , Humans , Male , Middle Aged , Angioplasty, Balloon, Coronary/mortality , Hospital Mortality , Myocardial Infarction/mortality , Thrombolytic Therapy/mortality , Fibrinolytic Agents/therapeutic use , Logistic Models , Myocardial Infarction/therapy , Risk Factors , Sex Factors , Streptokinase/therapeutic use , Tissue Plasminogen Activator/therapeutic use , Treatment OutcomeABSTRACT
Introducción: En el año 2004 publicamos los resultados intrahospitalarios del primer registro chileno de angioplastía coronaria (AC), RENAC. Sin embargo, la información nacional sobre los resultados alejados de la AC en Chile hasta la fecha ha sido escasa y parcelar. Objetivo: Evaluar los resultados alejados de la angioplastía coronaria en pacientes sin infarto agudo de miocardio (IAM) en el país. Pacientes y métodos: Seis de los 10 centros participantes en el RENAC entre junio de 2001 y octubre de 2002 efectúan seguimiento clínico alejado de sus pacientes. Resultados: De un total de 892 pacientes sin IAM sometidos a AC y dados de alta vivos, se obtuvo seguimiento clínico en 744 (83,3 por ciento) y en 772 (86,5 por ciento) sólo de su estado vital. La mayoría había presentado un síndrome coronario agudo y en el 88,7 por ciento fueron sometidos a angioplastía de un vaso. El 84,8 por ciento de las 936 lesiones fueron tratadas con stents. Se obtuvo éxito angiográfico en el 97,2 por ciento de las lesiones y clínico en un 97,6 por ciento de los pacientes. Al cabo de un seguimiento promedio de 21 meses, la mortalidad cardíaca fue de 0,9 por ciento y la total de 1,7 por ciento. Se efectuó una nueva revascularización del vaso tratado en el 5,5 por ciento de los pacientes. La sobrevida libre de eventos isquémicos mayores fue de 90,0 por ciento. Conclusiones: Los resultados extrahospitalarios de pacientes sin IAM y sometidos a AC en Chile muestran una baja mortalidad cardíaca, una baja frecuencia de revascularización del vaso tratado y una alta sobrevida libre de eventos isquémicos.
Background: In 2004 we published the in-hospital results of the first Chilean coronary angioplasty registry (RENAC). To date the long-term results of coronary angioplasty in Chile is scant. Aim: To assess the long-term results of coronary angioplasty in patients without acute myocardial infarction in Chile. Patients and Methods: Six out of 10 participating centers in RENAC between June 2001 and October 2002, providedclinical follow-up of their patients. Results: A total of 892 patients without acute myocardial infarction underwent angioplasty and were discharged alive. In 744 (83,3 percent) patients clinical follow-up was obtained and in 772 (86,5 percent) only vital status could be ascertained. Most patients underwent one vessel angioplasty (88,7 percent) for an acute coronary syndrome. Stent implantation was performed in 84,8 percent of the 936 treated coronary lesions. Angiographic success was obtained in 97,2 percent of lesions and clinical success in 97,6 percent of patients. After an average follow-up of 21 months, cardiac and all cause mortality were 0,9 and 1,7 percent. Target vessel revascularization was performed in 5,5 percent and survival free of cardiac ischemic events was 90,0 percent Conclusions: Long-term results of coronary angioplasty in patients without an acute myocardial infarction shows low rates of cardiac death, target vessel revascularization and a high survival free of cardiac ischemic events.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged, 80 and over , Angioplasty, Balloon, Coronary , Coronary Disease/therapy , Chile/epidemiology , Coronary Disease/mortality , Follow-Up Studies , Myocardial Infarction/epidemiology , Postoperative Period , Records , Myocardial Revascularization/statistics & numerical data , Stents , Survival Analysis , Treatment OutcomeABSTRACT
Antecedentes: El infarto del miocardio (IAM) tratado con trombolíticos tiene mayor mortalidad en mujeres que en hombres. Objetivo: Estudiar la mortalidad, según sexo, del IAM tratado mediante angioplastía primaria. Métodos: Se utilizaron los datos de los 3 últimos años del registro multicéntrico chileno de angioplastía coronaria (RENAC). Comparamos la mortalidad hospitalaria entre hombres y mujeres con IAM tratados con angioplastía primaria, ajustando las diferencias por edad, comorbilidad, número de vasos comprometidos, función ventricular y resultado de la angioplastía. Además se compararon entre ambos sexos la mortalidad por grupo etario y el intervalo entre el inicio de los síntomas y el tratamiento. Resultados: En el período analizado, en el RENAC existían 637 pacientes con IAM tratados con angioplastía primaria, 77 por ciento de los cuales eran hombres. La mortalidad hospitalaria fue 4.3 por ciento en hombres y 14 por ciento en mujeres (p<0.01). No hubo diferencias por sexo en el número de vasos comprometidos, fracción de eyección < 50 por ciento, uso de stents o en el éxito angiográfico (89 hombres vs 86 por ciento mujeres, ns). Las mujeres tenían mayor edad (65±12 vs 59±12 años, p<0.01), incidencia de diabetes (29 vs 19 por ciento, p<0.01) e hipertensión (78 vs 44 por ciento, p<0.01). En el análisis multivariado persistió el mayor riesgo de mortalidad en las mujeres (OR 3.29, 95 por ciento IC: 1.41-7.69, p = 0.006), pero sólo en el grupo > 70 años (24 vs 7 por ciento, p<0.01). Conclusión: En personas menores de 70 años, la angioplastía primaria permitiría disminuir la diferencia pronóstica del IAM entre mujeres y hombres.